Get Live Data

Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. SUPP.L Share Price
  4. SUPP.L Share Regulatory News
  5. Change of Name

Pin to quick picksSUPP.L Regulatory News (SUPP)

SUPP.L Information
  • There is currently no data for SUPP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Name

20 Apr 2023 15:55

RNS Number : 9591W
Schroder UK Public Private Tst plc
20 April 2023
 

SCHRODERS CAPITAL GLOBAL INNOVATION TRUST PLC

(formerly Schroder UK Public Private Trust plc)

(the 'Company')

 

CHANGE OF NAME

 

Legal Entity Identifier: 2138008X94M7OVE73177

 

The Board is pleased to announce that, as stated in the Report and Accounts for the year ended 31 December 2022, in order to better reflect the Company's current investment objective, the Company has today changed its name to Schroders Capital Global Innovation Trust plc. The London Stock Exchange stock ticker symbol (TIDM) will also change from SUPP to INOV with effect from 8.00am on 21 April 2023. The Company's ISIN, SEDOL, and LEI remain unchanged.

 

The Company's website address will shortly be renamed www.schroders.com/inov

 

 

20 April 2023

 

For further information, please contact:

 

Schroder Investment Management Limited

Shilla Pindoria (Company Secretary)

Tel: +44 (0)20 7658 6000

 

Augustine Chipungu (PR)

Tel: +44 (0)20 7658 6000

 

John Spedding

Tel: +44 (0)20 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANFLFESSLIIFIV
12345678910
Date   Source Headline
9th Dec 202210:34 amRNSNet Asset Value(s)
8th Dec 202210:54 amRNSNet Asset Value(s)
7th Dec 20224:47 pmRNSTransaction in Own Shares
7th Dec 202210:51 amRNSNet Asset Value(s)
6th Dec 202210:47 amRNSNet Asset Value(s)
5th Dec 202210:40 amRNSNet Asset Value(s)
2nd Dec 202210:46 amRNSNet Asset Value(s)
1st Dec 202211:51 amRNSNet Asset Value(s)
30th Nov 20225:24 pmRNSTotal Voting Rights
30th Nov 202210:39 amRNSNet Asset Value(s)
29th Nov 20225:10 pmRNSTransaction in Own Shares
29th Nov 202210:52 amRNSNet Asset Value(s)
28th Nov 202210:56 amRNSNet Asset Value(s)
25th Nov 202210:58 amRNSNet Asset Value(s)
24th Nov 202211:49 amRNSNet Asset Value(s)
23rd Nov 20224:56 pmRNSTransaction in Own Shares
23rd Nov 202210:39 amRNSNet Asset Value(s)
22nd Nov 202211:30 amRNSNet Asset Value(s)
21st Nov 202211:17 amRNSNet Asset Value(s)
18th Nov 202211:24 amRNSNet Asset Value(s)
17th Nov 20224:55 pmRNSTransaction in Own Shares
17th Nov 202211:13 amRNSNet Asset Value(s)
17th Nov 20227:00 amRNSInvestment in A2 Biotherapeutics
16th Nov 202211:01 amRNSNet Asset Value(s)
15th Nov 202211:23 amRNSNet Asset Value(s)
14th Nov 202211:32 amRNSNet Asset Value(s)
11th Nov 202211:32 amRNSNet Asset Value(s)
10th Nov 202211:35 amRNSNet Asset Value(s)
9th Nov 20224:40 pmRNSSecond Price Monitoring Extn
9th Nov 20224:35 pmRNSPrice Monitoring Extension
9th Nov 202211:46 amRNSNet Asset Value(s)
8th Nov 202211:41 amRNSNet Asset Value(s)
7th Nov 20224:54 pmRNSTransaction in Own Shares
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Nov 202211:51 amRNSNet Asset Value(s)
4th Nov 20225:58 pmRNSTransaction in Own Shares
4th Nov 20224:41 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 202211:53 amRNSNet Asset Value(s)
4th Nov 20227:00 amRNSInvestment in iOnctura
3rd Nov 20225:09 pmRNSTransaction in Own Shares
3rd Nov 202211:23 amRNSNet Asset Value(s)
2nd Nov 20225:43 pmRNSTransaction in Own Shares
2nd Nov 202211:06 amRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
1st Nov 202211:16 amRNSNet Asset Value(s)
31st Oct 20225:30 pmRNSTotal Voting Rights
31st Oct 20225:17 pmRNSTransaction in Own Shares
31st Oct 202211:31 amRNSNet Asset Value(s)
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.